Invest in Pharmaceuticals business Africa

In Cote d’Ivoire, 6% of pharmaceutical products are domestically produced, while 94% is imported, signifying a huge area for improvement.

$1.8 Bn by 2025

Forecast

he Ivorian pharmaceutical market is projected to reach USD 1.8 billion by 2025 (Statista), fueled by factors like a growing population, rising disposable incomes, and an increasing focus on healthcare access. This significant market expansion creates a lucrative space for ZIC-based manufacturers to cater to domestic needs and contribute to import substitution. Prioritizing the production of essential medicines can ensure a steady demand and contribute to improved healthcare access within Côte d'Ivoire and neighboring countries. Meeting international quality standards like WHO Good Manufacturing Practices (GMP) is crucial for gaining market trust and potentially exporting pharmaceuticals.

ZIC's proximity to Abidjan's port facilitates easy import of raw materials and export of finished pharmaceutical products. This strategic positioning allows companies to tap into regional markets within the Economic Community of West African States (ECOWAS), with a combined population exceeding 200 million (World Bank), offering significant export potential. Additionally, potential trade agreements within ECOWAS can further streamline regional pharmaceutical trade.

FACILITIES IN PEIA Pharmaceuticals